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Abstract 
Tumor Necrosis Factor alpha (TNF) initiates a complex series of biochemical events in 
the cell upon binding to its type R1 receptor (TNF-R1). Recent experimental work has 
unravelled the molecular regulation of the recruitment of initial signaling complexes 
that lead either to cell survival or death. Survival signals are activated by direct binding 
of TNF to TNF-R1 at the cell membrane whereas apoptotic signals by endocytosed 
TNF/TNF-R1 complexes. Here we investigate these aspects by developing a 
quantitative mathematical model of TNF binding, internalization and intracellular 
signaling. Model outputs compare favorably with experimental data and allow to 
compute TNF-mediated cytotoxicity as observed in different cell systems. We 
extensively study the space of parameters to show that the model is structurally stable 
and robust over a broad range of parameter values. Thus, our model is suitable for 
implementation in multi-scale simulation programs that are presently under 
development to study the behavior of large tumor cell populations. 
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Introduction 
Tumor Necrosis Factor alpha (TNF) is a cytokine that acts as a key regulator of immune 
functions, and indeed it exerts pleiotropic effects in immunity, inflammation, control of 
cell proliferation, differentiation and apoptosis (1-3). Other molecules share with TNF 
part of its effects and, not suprisingly, they are all evolutionarily related to TNF (4). It is 
now recognized that TNF is the prototypical member of a growing family of cytokines 
(4) but, unlike the other members, TNF can trigger intracellular signals that lead either 
to cell survival and proliferation or death (1-4). This dual role is important as far as the 
regulation of immune response is concerned, since it acts as a molecular basis for 
cellular homeostasis. However, TNF is also a natural anti-tumor molecule and these 
opposing signals might lead to inhibition of tumor growth or, at the opposite, in the 
promotion of tumor development through direct (see e.g. ref. 5) and indirect 
mechanisms (e.g. by tissue remodelling and stromal development. See e.g. ref. 6). 
Dissecting out the molecular mechanisms of TNF signaling is therefore crucial. 
Several works have addressed the biochemical pathways of the TNF signaling cascade 
in a variety of cells and many molecular actors of this complex intracellular machinery 
have been discovered and studied (for a comprehensive review see ref. 7). The 
astonishing complexity of the signal transduction machinery triggered by TNF has also 
attracted the attention of modelers who, using modern approaches common in systems 
biology, have attempted to unravel the switching mechanism between the pathways 
leading to cell survival or death through mathematical modeling and theoretical analysis 
(8-12). These works have been focused on the interplay among intracellular molecules 
and on the network of reactions stimulated by binding of TNF on its type 1 receptor 
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(TNF-R1). Recent data have clearly shown that the path that leads to cell survival is 
triggered by TNF binding to its receptor at the cell surface whereas the cell death 
pathway is triggered by internalized TNF/receptor complexes (13,14).  
Here we focus on this important bifurcation between the two paths that occur early upon 
binding of TNF to TNF-R1, and develop a minimal model of TNF action that is suitable 
for inclusion in a numerical program that we are currently developing to study tumor 
spheroids (15,16). The actual feasibility of such a simulation program depends critically 
on a series of simplification steps, and in particular we proceed in a partly 
phenomenological way that leads to straightforward parameterizations. The present 
model follows the same basic principles and replaces some complex molecular 
pathways with simpler mechanisms, and yet it successfully captures the basic features 
of experimental toxicity data. 
In the next sections, we briefly review current biological knowledge on TNF signaling 
in cells. Then we present the model and show how model outputs compare with actual 
data. Finally we explore the parameter space over a wide range of parameter values to 
investigate the structural stability and robustness of the numerical model.  
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Modeling TNF activity on cells 
A short review of TNF biology 
For the sake of clarity, we briefly review the basic facts on TNF. More detailed 
descriptions can be found in recent reviews such as (7). 
TNF is a homotrimeric molecule that binds to two different receptors: TNF-R1 and 
TNF-R2 (7). TNF-R1 appears to be the key mediator of TNF signaling in both normal 
and tumor cells and for this reason we focus our analysis on this receptor. TNF-R1 has 
three subunits, and their cytoplasmic tails must be juxtaposd to trigger intracellular 
signaling. Two models of TNF-R1 subunits recruitment have been proposed over the 
years: the first assumes that the receptor subunits juxtapose upon binding of 
homotrimeric TNF which, therefore, would drive the assembly of active TNF-R1; the 
second, which is supported by recent experimental evidences, suggests that TNF-R1 
subunits self-assemble in the absence of TNF thanks to a conserved extracellular 
domain called the Pre-Ligand Assembly Domain (PLAD, 17). In this case, signaling by 
pre-assembled receptors before TNF binding would be prevented by cytosolic negative 
regulators sych as the Silencer of Death Domain (SODD, 18). 
Binding of TNF to TNF-R1 initiates a series of biochemical events in the cell that take 
place at the cytoplasmic tails of the receptor subunits and, in particular, at their 
specialized domains called Death Domains (DD). DD recruit the adaptor protein 
TRADD that acts as an assembly platform for at least two other proteins, RIP-1 and 
TRAF-2 (2, 3, 7). This multiproteic complex initiates the signaling cascades resulting in 
NF-κB activation and hence gene activation and cell survival (2, 3, 7). Among the genes 
that are expressed after NF-κB activation, there are those that code for the two proteins 
FLIP and IAP that inhibit the TNF apoptotic pathway (2, 3, 7).   
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It has been recently demonstrated that the TNF apoptotic pathway is initiated by 
TNF/TNF-R1 complexes internalized into endocytic vesicles (14). At this intracellular 
level, the multiproteic complexes associated to the receptors' tails modify and form the 
so-called Death Inducing Signaling Complex (DISC, 14), whereby TRADD recruits 
FADD and pro-caspase-8. This caspase then triggers the irreversible pathway leading to 
apoptosis and cell death. It has also been demonstrated that the fate of endosomes 
containing TNF/TNF-R1 complexes prior to their maturation into lysosomes is to fuse 
with vesicles from the trans-Golgi network (14). They may contain two inactivated 
enzymes, pro-A-SMase and pre-pro-CTSD, whose activation is also triggered by the 
multiproteic complexes formed at the TNF-R1 cytoplasmic tails upon the formation of 
the multivesicle structure, and in particular by active caspase-8. Activation of A-
SMase/CTSD cascade is also capable of mediating apoptosis via Bid cleavage and 
caspase-9 activation (14).  
Both the NF-κB and the apoptotic pathways comprise a series of complex intracellular 
reactions involving a number of enzymes and substrates (2, 3, 7). These have been the 
subject of intense modeling efforts aimed at explaining the response of individual cells 
to TNF from a systemic perspective at the molecular level (8-12). To the best of our 
knowledge these models do not focus on the different timing of the two pathways, but 
rather on the switching dynamics of the underlying biochemical system, resulting from 
feedback motifs detected at subcellular level. Indeed, current biological data indicate 
that activation of NF-κB and caspases occurs at different sites in the cells (at the cell 
membrane and upon internalization in endosome, respectively), at different times.  
 
Binding and internalization of TNF/TFN-R1 complexes 
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Current biochemical data show that the TNF-R1 receptors rapidly self-trimerize at the 
cell membrane because of the PLAD domains and interact with TNF homotrimers (17). 
Thus, the mechanism of TNF binding to TNF-R1 can in principle be viewed as the 
result of the monomeric interactions between one molecule of TNF and one molecule of 
receptor. This semplification is futher supported by the following considerations: 
1. the mechanism of receptor self-trimerization followed by ligand binding can be 
modeled by a set of 5 differential equations with 6 parameters. The model can fit 
experimental data of TNF binding, but one finds that the kinetics of receptor 
trimerization are much faster than the binding kinetics, and thus the trimerized receptor 
behaves as an effective monomer. In addition, experimental determinations of the 
parameter values for intermediate binding reactions are not available; 
2. experimental data of TNF dose-dependent binding to cells or of TNF binding kinetics 
have already been succesfully fitted with mathematical models that do not take into 
consideration the trimerization of receptors, neither TNF-induced nor TNF-independent, 
but, on the contrary, by classical models based on the law of mass action between two 
molecules (19-21). 
In a series of papers, Vuk-Pavlović and colleagues (19, 20) systematically investigated a 
number of models of TNF binding and internalization in cells and, by quantitative 
comparison with actual experimental data, they produced a satisfactory basic model. 
Since the model by Bajzer et al. (19) fitted experimental data well, we use it to describe 
the early events of TNF interactions with cells.  
However the original model of Bajzer et al. (19) must be updated to account for some 
novel aspects of TNF biology. In particular, Bajzer et al. assumed that internalized 
ligand/receptor complexes could be recycled back at the cell surface (19). Recent data, 
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however, show that the final fate of the endosomes containing TNF complexes is to 
maturate to lysosomes by progressive fusion with vesicles from the trans-Golgi network 
loaded with lysosomal enzymes (see also the previous section and ref. 14), and thus it is 
highly probable that TNF/TNF-R1 complexes do not recycle at all but are finally 
degraded into lysosomes. Therefore we modify the model by Bajzer et al. as follows 
(see also Fig.1): 
d[R]
dt = Vr − kd[R]− kon[L][R]+ koff [Nc]
d[L]
dt = −kon[L][R]+ koff [Nc]
d[Nc]
dt = kon[L][R]− (koff + kin )[Nc]
d[Nin]
dt = kin[Nc]− kdeg[Nin]
   [1] 
where square brackets denote molar concentrations of free TNF-R1 receptors (R), free 
TNF (L), TNF/TNF-R1 complexes bound at the cell membrane (Nc) and internalized 
complexes (Nin). Here kon and koff are the association and dissociation rate constants for 
TNF binding to TNF-R1, respectively, kin is the internalization rate constant of 
TNF/TNF-R1 complexes and kdeg is the rate constant of lysosomal degradation of the 
complexes.  
The two parameters Vr and kd where introduced by Bajzer et al. (19), although with a 
slightly different notation, to describe “the zero-order rate of insertion of receptors into 
the membrane and the turnover (internalization) rate constant of ligand-free receptors” 
(19, 20) respectively.  This is an important aspect of the model since, in the absence of 
TNF, it reaches a steady concentration of receptors at the cell surface given by: 
[R][L ]=0 =
Vr
kd
       [2] 
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In addition, for long times these terms prevent receptor loss (i.e. downmodulation) from 
the cell surface, a process that would undesirably result in cell resistance to TNF 
independently of the dynamic interplay between the intracellular paths triggered by 
TNF. 
 
Modeling the intracellular signaling pathways triggered by TNF  
Fig.1 shows how our minimal model maps onto the main biochemical paths triggered 
by TNF binding to its receptors. The figure, and hence our modeling effort, has been 
inspired by the recent work of Schneider-Brachet et al. (14) that elegantly demonstrates 
that the pathway leading to NF-κB activation and cell survival is initiated at the cells 
surface upon the formation of TNF/TNF-R1 complexes, whereas the one that leads to 
apoptosis and cell death by internalized complexes. In addition to the basic observations 
by Schneider-Brachet et al., we have integrated this circuits by implementing the NF-
κB-mediated transcription of genes coding for caspase-8 inhibitors such as FLIP. In this 
way, the two intracellular pathways interact dynamically, inasmuch as the cell survival 
pathway - that starts earlier since it does not require internalization of TNF/TNF-R1 
complexes - can inhibit the apoptotic path.  
Here we model both biochemical circuits by means of only two molecular species, that 
we denote with B and A, that collectively summarize the various reactions leading to 
cell survival and death, respectively, and the interplay between the two paths. The, 
molecules B and A can be loosely identified with NF-κB/FLIP and caspase-8, 
respectively (Fig.1). We assume that after the initial trigger both pathways proceed 
irreversibly to their endpoint. In this way we neglect many details of both pathways 
which involve a number of different molecular actors, and thus we neglect all those 
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reactions that probabily serve to fine tune the effects of TNF. Finally, we introduce a 
population variable f (t) , the fraction of surviving cells at time t . The equations for A 
and B are: 
d[B]
dt = β[Nc]− kBdeg[B]
d[A]
dt = α[Nin]− γ [B][A]− kAdeg[A]
df (t)
dt = −κ[A] f (t)
    [3] 
where the variables Nc and Nin are the same as in the differential system [1].  
We see from the differential system [3], that the cell survival signal, modeled 
phenomenologically by means of the chemical species B, depends on the number of 
TNF-TNF-R1 complexes at the cell surface (e.g. Nc), with rate constant parameter β. 
On the other hand,  the apoptotic signal, modeled phenomenologically by means of the 
chemical species A, depends on the number of internalized ligand/receptor complexes 
(e.g. Nin) with rate constant α. The cell survival pathway inhibits the apoptotic one by 
destroying A with rate γ B[ ] . Finally, both B and A can be degraded by means of 
ubiquitination and proteasome cleavage and/or irreversibly inhibited by other molecular 
species, and these processes are described by the rate constants kBdeg and kAdeg, 
respectively. 
The surviving fraction f (t)  has also a probabilistic meaning at the single-cell level, 
since κ[A]dt  is the (Poisson) probability that a single cell dies during the time interval 
(t, t+dt). This function, therefore, models cell death as a single-hit mechanism with rate 
κ[A] ,  and this notion is supported by a number of different cytotoxicity experiments 
(see e.g. refs. 22-26). Notice also that if [A] is kept constant we recover a familiar 
formula for the surviving fraction (22, 26): 
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f (Δt) = e −κ A[ ]Δt( )        [4] 
 
Mathematical methods 
Eventually, the systems of equations [1] and [3] define a complete model of TNF 
bioactivity on target cells, and we have used the Mathematica programming 
environment to carry out all integrations, fits and robustness tests (Wolfram Research, 
Inc., 100 Trade Center Drive, Champaign, IL, U.S.A.). 
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Results 
Binding and internalization kinetics 
We have estimated the parameters related to TNF binding and internalization by fitting 
equations [1] to available experimental data. The choice of the appropriate data, 
however, is not trivial. Fitting of equations [1], in fact, requires a priori knowledge of: 
1. number of cells used in the assays and number of receptor molecules per cell, in order 
to fix the initial value for the variable [R] ; 
2. effective free TNF concentration in the experiment (in general TNF is labelled with 
radioactive isotopes such as 125I, and it would be important to know if TNF has retained 
full biological activity after the labeling procedure); 
3. specific activity of labeled TNF in order to convert e.g. radioactive counts to grams 
of TNF and finally to moles units; 
4. reaction volume to convert data to concentration units; 
5. fraction of internalized TNF molecules that undergo proteolysis. 
The latter point is particularly important for experiments that last several hours, where 
the degradation kinetics is expected to contribute much to the degradation of 
internalized molecules. From an experimental point of view, this fraction can be 
estimated by measuring the amount of radioactivity that cannot be precipitated by, e.g., 
trichloroacetic acid (or (NH4)2SO4) in cell extracts after removing bound TNF from cell 
membranes (e.g. by treating cells with mild acidic solutions at 4 ºC or by other means) 
(27). Finally, we take into account only experiments carried out at 37 ºC, where 
internalization proceeds normally, and not at 4 ºC.  
After extensive search of the scientific literature we found that the experiments in (21) 
match most of the above conditions. Grell et al. (21) used HeLa cells that express only 
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the isoform R1 of the TNF receptor at a reported amount of approximately 3000 
molecules per cell. The number of cells used and the residual biological activity of 
labeled TNF were also given. Finally experiments were carried out at 37 ºC and lasted 
15 minutes, thus allowing TNF molecules to internalize and only a small fraction 
thereof to reach the lysosomes where degradation can occur (28). Since Grell et al. (21) 
did not discriminate between bound and internalized TNF molecules, the sum 
Nc[ ](t) + Nin[ ](t)  was fitted to experimental data of total cell-associated radioactivity. 
Fig.1 shows the data in (21) along with the best fit to the data using the set of 
differential equations [1].  
Although the data set contains only 9 data points and the model has 6 parameters, the fit 
can still be performed, (we find χ 2 = 9.0 , which corresponds to a 3% statistical 
significance) , and the estimated parameter values are as follows: 
Vr = 1 ⋅10−12M ⋅min−1 , kd = 0.1 ⋅min−1 , kon = 6.5 ⋅108M −1 ⋅min−1 , koff = 0.1 ⋅min−1 , 
kin = 0.05 ⋅min−1  and kdeg = 0.16 ⋅min−1 . Unfortunately, the small number of available 
experimental data did not allow us to estimate the error bounds for the parameter values.  
 
Dose-response cytotoxicity assays 
Grell et al. (21) reported dose-response data with HeLa cells. However, cell viability 
was measured by spectrophotometry upon crystal violet staining of the cells and 
background values were not given. We therefore chose to compare model outputs with 
the data in Scherf et al. (29). These authors measured TNF cytotoxicity against MCF7 
(human breast carcinoma cells) and Colo205 (human colon carcinoma cells) by the 
3[H]-leucine incorporation assay, a method that provides very low background values. 
Unfortunately: 
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1. to the best of our knowledge the number of TNF receptors per cell is not known for 
these tumor cell lines; 
2. dose-response cytotoxicity assays measure cell killing at different doses of a drug, 
and these are generally obtained by logarithmic serial dilutions (typically 10-fold) of 
TNF stocks. As a consequence, experimental data are limited and the goodness of fit 
cannot be statistically evaluated.  
Presently we do not aim at precise parameter estimates for a specific cell line, but rather 
at a general test of the validity of the model; we also seek to determine its robustness 
with respect to parameter changes (see also the Discussion section).    
Therefore we used equations [1] with the parameter values given above to model TNF 
binding and internalization and then attempted to fit cytotoxicity data in (29) using 
equations [3]. The initial conditions that are needed to solve the differential system were 
taken from the experiments by Scherf et al. (29), that were carried out by plating a 
different number of cells in a higher volume of growth medium rather than those by 
Grell et al. (21). The results are shown in Fig.3. 
The estimated parameter values are as follows:  
1. MCF7 cells: α = 0.071 min−1 , β = 0.33 min−1 , γ = 1.2 ⋅1010  M-1 ⋅min−1 , 
kAdeg = kBdeg = 0.033 min−1 , κ = 6.1 ⋅109M −1 ⋅  min−1 ; 
2. Colo205 cells: α = 0.071 min−1 , β = 0.33 min−1 , γ = 1.15 ⋅1010  M-1 ⋅min−1 , 
kAdeg = 0.033 min−1 , kBdeg = 0.018 min−1 , κ = 4.0 ⋅109M −1 ⋅  min−1 . 
To test the stability of the outputs in Fig.3 we simulated the cytotoxic effects for MCF7 
cells at different TNF doses administered for increasing times. The results in Fig.4 show 
that the simulated cytotoxic effects saturates after approximately 44 hours, and that no 
further TNF-mediated cytotoxicity can be observed after that time. It is worth noting 
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that the maximal observed cytotoxic effect in Fig.4 corresponds to a surviving fraction 
f = 0.038 . That is to say, 3.8 % of the cells survive independently of TNF 
concentration and treatment time. 
 
Exploring the space of parameters 
Our model of TNF cytotoxicity is collectively given by equations [1], describing uptake 
and internalization of TNF, and equations [3], describing intracellular processes 
activated by TNF that lead to either cell survival or death. Parameter values in equations 
[1] have been estimated by fitting with a good level of statistical significance, and all 
the model assumptions can be subjected to experimental validation. Model equations 
[3], instead, describe phenomenologically the intricate web of molecular interactions 
that constitute the intracellular signal transduction machinery triggered by binding of 
TNF to TNF-R1. The paucity of experimental data (see e.g. ref. 30) makes it difficult to 
compare model outputs with specific experimental observations. In this case it is 
important to study whether the model can still provide reasonable outputs, or fail,  for a 
broad range of parameter values.   
Model equations [3] contain 5 independent parameters, namely α , β , γ , kAdeg  and 
kBdeg  that tune the intracellular activation  and degradation of molecules A and B and 
their interactions. Parameter κ  models cell death as a single-hit mechanism depending 
on the concentration of molecule A, and thus the exponential behaviour of the function 
f (t)  (see equation [4]) is not altered by the different choice of  κ  values that can only 
adjust the shape of the sigmoid curve that describes the surviving fraction. Thus, the 
space of the parameters is effectively 5-dimensional  and here we explore several 
sections of this space as a function of TNF concentration. 
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Fig.5 shows the model outputs calculated for a broad range of parameter values as a 
function of TNF concentrations in the range 11-14-11-9M. The output is the maximum 
fraction of surviving cells that can resist a given amount of TNF after a very long time 
treatment (i.e., lim
t→∞
f (t) = f (∞) ), and this was calculated after 20.000 min (approx. 14 
days) of TNF treatment to allow any transient to settle down. In Fig.6 we also change 
the values of two parameters at the same time. In this case TNF concentration was set to 
1.7 ⋅10−11M , which is the IC50 for MCF7 cells (IC50 = concentration that inhibit 50% 
cell survival, see Fig.3).  
Results in both Fig.5 and Fig.6 show that no unexpected and/or undesired patterns 
emerge, and that the model actually describes a balance between cell survival and death 
for a broad range of parameter values. Thus the model is structurally stable and robust 
with respect to parameter variations. 
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Discussion 
We have developed a minimal quantitative model of TNF cytotoxicity. The model is 
minimal because it takes into consideration only those reactions that, in our opinion, are 
essential to describe the action of TNF on cell survival and death.  
We have modeled TNF binding and its uptake by cells, and it is worth noting that the 
estimated parameter values are biologically relevant. In fact: 
1. the ratio Vrkd
 (equation [2]) determines the concentration of TNF receptors in the cell 
population at equilibrium. Substituting the estimated values, we obtain 
[R][L ]=0 = 10−11M and, considering the experiments by Grell et al. (21) where 
approximately 4.5 ⋅105  cells were used in a reaction volume of 150 µl, we find that 
each cells expresses on average approx. 2.26 ⋅103 TNF receptors (which corresponds to 
a measured concentration of 1.126 ⋅10−11M ). This value is in good agreement with 
experimental data collected with HeLa cells (21); 
2. the dissociation constant at equilibrium is defined as Kd =
koff
kon
. Using the above 
values, Kd = 1.5 ⋅10−10M −1  approximately 10 times higher than reported by Grell et al. 
(21) for HeLa cells. However, these authors estimated the dissociation constant by non-
linear regression of experimental data with standard binding equations and they did not 
take into account internalization of bound molecules; 
3. internalization and degradation rate constants show values that are in a reasonable 
range from a biological perspective. In fact they imply that, on average, the 
characteristic time of TNF internalization (at the considered concentration) is 20 min 
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and that approximately 6 more minutes are required by internalized complexes to reach 
the lysosomes where degradation occurs (28). 
Moreover the rate constant β  parameterizes the triggering kinetics of the survival signal 
that initiates at the cell membrane level upon binding of TNF to TNF-R1. From its 
estimated value, we can calculate that the survival signal is very quick and starts within 
a few minutes (approximately 3 min) after TNF binding. Using mutant cells expressing 
a TNF-R1 where the internalization domain - called TRID - was deleted (TNF-R1 
ΔTRID), Schneider-Brachert et al. (14) clearly demonstrated that within 3 min after 
receptor activation, a complex of adaptor proteins (consisting of RIP-1 and TRAF-2) is 
formed at the cell surface, signaling for NF-κB activation and cell survival. However, 
the proteins TRADD, FADD and caspase-8 were not recruited, demonstrating the 
endocytosis and DISC formation are inseparable events (14). Thus, survival and death 
signals are temporarily separated and this is reflected in our model by the differences 
between the values of the parameters α and β. 
We have extensively explored the parameter space of the model. Simulations show that 
the model has a stable behavior for a broad range of parameter values and that no 
unexpected patterns emerge (such as oscillations, chaos, etc.). Thus the model is 
structurally stable: obviously this is quite important and lends credibility to the model, 
because this indicates that different cells with unequal expression of key substrates and 
enzymes and/or showing a signal transduction network with a different topology have 
similar responses to TNF. This also means that our model is not specific for a given cell 
type and that it can be used to simulate the effects of TNF independently of the 
experimental settings of the original data on which the parameter estimate is based.    
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In our model there is no switching mechanism that selects cell survival or death signals, 
but rather a balance between the two pathways that produces partial cell killing even for 
long lasting and intense TNF treatments. The balance depends on environmental TNF 
concentration, and this observation might be important to explain cellular homeostasis 
during an immune response, i.e. the fine equilibrium between cellular activation and 
death (1). This equilibrium might further be balanced in favour of cell survival or death 
in real cells by the fine expression and/or degradation of intracellular molecular actors 
that transduce TNF signals (for example, in our model cell survival can be improved by 
increasing degradation of A and/or the expression of B molecules. See also ref. 5).   
The model nicely fits cytotoxicity data with tumor cells. There is an increasing interest 
in modeling tumor growth and behaviors, and multi-scale models are now under 
development (15, 16, 31-34, and references cited therein). Our model of TNF 
cytotoxicity provides outputs in quantitative agreement with actual data, and it is robust 
to parameter changes. Moreover, a true fit of the model equations to experimental data 
is possible in this case because of the low number of model parameters, far fewer than 
those considered in current models that approach the TNF signal transduction pathways 
from a systemic perspective (e.g. > 50 parameters as in ref. 8). Obviously, parameter 
reduction also means that many details of the underlying biology must be neglected, but 
in this way the essential features of a biological mechanism - such as TNF action on 
cells - can be clearly investigated, captured, controlled and eventually implemented into 
more complex models of the cell. Further details of the TNF signal transduction 
machinery could then be added using the present model as a starting point.  
Because of its favorable properties, our model is suitable for integration into complex 
multi-scale simulation programs of tumor growth such as VBL (15, 16). We plan to use 
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the model to explore in detail the response of tumor cell clusters to TNF therapy and to 
investigate tumor/immune system interaction dynamics. 
 21 
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Figure Legends 
Fig.1 - Modeling TNF cytotoxicity. A. Biological view of the main TNF paths (redrawn 
from 14). Binding of TNF to TNF-R1 recruits a molecular complex formed by TRADD, 
RIP-2 and TRAF-2, signaling for NF-κB activation, cell survival and expression of 
caspase inhibitors such as FLIP. During endocytosis, TRADD, FADD and caspase-8 are 
recruited to form the TNF-R1 associated DISC. Caspase-8 is autocatalytically cleaved 
during receptosome trafficking. B. Scheme of the biochemical paths that have been 
considered in the present model. TNF binds to TNF-R1 with association and 
dissociation rate constants given by kon and koff  and the complexes are internalized with 
rate constant kin . Binding activates signaling resulting in the formation of a molecule B 
with rate constant β . Molecule B inhibits the apoptotic signal which has been assumed 
to be proportional to the concentration of molecule A, and this process occurs with rate 
constant γ . The apoptotic signal A is triggered by internalized TNF/TNF-R1 complexes 
with rate constant α . Internalized receptors are finally degraded into lysosomes, and 
both molecular signals A and B are cleared off by proteolytic cleavage or by inhibitory 
binding with other molecules (rate constants kdeg , kAdeg  and kBdeg , respectively). 
Equilibrium in the expression and downmodulation of TNF receptors have been 
assumed to occur at the cell surface (rate constants Vr  and kd . See also ref. 19 and the 
text for details). 
 
Fig.2 - Binding kinetics of TNF at 37 ºC. Symbols have been redrawn from (21) and 
refer to experiments carried out with HeLa cells. The curve represent the best fitting 
obtained with model equations [1]. 
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Fig.3 - Fitting dose-response cytotoxicity data with the whole model. Data have been 
redrawn from (29) and refer to experiments carried out with MCF7 (black symbols) or 
Colo205 (grey symbols). The curves show the best fits of experimental data with 
equations [1] and [3]. Parameters in equations [1] assume the values estimated by fitting 
of binding kinetics data as shown in Fig.2. Experimental error was not given in the 
original data.  
 
Fig.4 - Computing TNF cytotoxicity as a function of both TNF concentration and time. 
Simulations were carried out using the parameter values estimated by fitting 
cytotoxicity data collected with MCF7 cells. The fraction of surviving cells has been 
computed after 1, 2, 4, 6, 8, ..., 48 hours of treatment.  
 
Fig.5 - Robustness of the model with respect to parameter changes. Key parameters 
describing the intracellular paths triggered by TNF binding to TNF-R1 were varied over 
a broad range of values, and model outputs have been computed at each indicated TNF 
concentrations. Outputs refer to the fraction of cells surviving treatment after 20.000 
min ( f (∞) ) and the corresponding values in panels A-E are given in gray scale colors. 
These can be compared to the reference bar given on top.  
 
Fig.6 - Robustness of the model with respect to parameter changes. See the legend of 
Fig.5 and the text for details. Here, we varied the values of two parameters at the same 
time and explore different combinations of model parameters. The surviving fraction 
was computed for a fixed concentration of TNF that was set at the IC50 value measured 
for MCF7 cells (see Fig.3).  
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